Eulàlia Grau

769 total citations
13 papers, 332 citations indexed

About

Eulàlia Grau is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Eulàlia Grau has authored 13 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Infectious Diseases and 3 papers in Immunology. Recurrent topics in Eulàlia Grau's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). Eulàlia Grau is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (6 papers). Eulàlia Grau collaborates with scholars based in Spain, Switzerland and United States. Eulàlia Grau's co-authors include Bonaventura Clotet, Cecilio López‐Galíndez, José Moltó, Alain Pruvost, Henri Bénech, Jacques Grassi, Jordi Puig, Lidia Ruíz, Frédéric Théodoro and Eugènia Negredo and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Eulàlia Grau

13 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eulàlia Grau Spain 9 250 213 85 54 50 13 332
Kavidha Reddy United States 6 323 1.3× 227 1.1× 107 1.3× 34 0.6× 69 1.4× 12 346
Sara Karandish United States 3 247 1.0× 157 0.7× 103 1.2× 83 1.5× 52 1.0× 4 318
Jean Pierre Routy Canada 6 211 0.8× 186 0.9× 38 0.4× 33 0.6× 66 1.3× 9 268
Elisabet García Spain 10 284 1.1× 213 1.0× 103 1.2× 66 1.2× 95 1.9× 28 387
Roy M. Matining United States 8 185 0.7× 208 1.0× 44 0.5× 44 0.8× 79 1.6× 13 331
Stéphane De Wit Belgium 10 196 0.8× 185 0.9× 45 0.5× 64 1.2× 92 1.8× 18 319
Sekar Natesampillai United States 13 301 1.2× 164 0.8× 199 2.3× 104 1.9× 84 1.7× 22 413
Manel Crespo Spain 12 241 1.0× 202 0.9× 103 1.2× 59 1.1× 168 3.4× 19 425
Kenneth Lynn United States 8 236 0.9× 118 0.6× 181 2.1× 45 0.8× 75 1.5× 13 344
Shayne Loubser South Africa 8 242 1.0× 216 1.0× 76 0.9× 30 0.6× 50 1.0× 22 316

Countries citing papers authored by Eulàlia Grau

Since Specialization
Citations

This map shows the geographic impact of Eulàlia Grau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eulàlia Grau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eulàlia Grau more than expected).

Fields of papers citing papers by Eulàlia Grau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eulàlia Grau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eulàlia Grau. The network helps show where Eulàlia Grau may publish in the future.

Co-authorship network of co-authors of Eulàlia Grau

This figure shows the co-authorship network connecting the top 25 collaborators of Eulàlia Grau. A scholar is included among the top collaborators of Eulàlia Grau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eulàlia Grau. Eulàlia Grau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pradenas, Edwards, Víctor Urrea, Sílvia Marfil, et al.. (2025). Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters. Journal of Translational Medicine. 23(1). 783–783. 2 indexed citations
2.
Urrea, Víctor, Cristina Gálvez, Sara Morón‐López, et al.. (2024). Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir. Journal of Clinical Investigation. 135(2). 3 indexed citations
3.
Gonzàlez, Núria, Krisha McKee, Rebecca M. Lynch, et al.. (2018). Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors. PLoS ONE. 13(3). e0193773–e0193773. 21 indexed citations
4.
León, Agathe, Ignacio Pérez, Ezequiel Ruíz-Mateos, et al.. (2016). Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS. 30(8). 1209–1220. 60 indexed citations
5.
Casado, Concha, María Pernas, Virginia Martin, et al.. (2013). Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses. PLoS ONE. 8(10). e77663–e77663. 17 indexed citations
6.
Pernas, María, Concha Casado, Virginia Martin, et al.. (2013). Prevalence of HIV-1 Dual Infection in Long-Term Nonprogressor–Elite Controllers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(3). 225–231. 7 indexed citations
7.
Ballana, Ester, Beatriz Mothe, Eva Ramírez de Arellano, et al.. (2012). Differential prevalence of the HLA-C −35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology. 217(9). 889–894. 19 indexed citations
8.
Pernas, María, Concha Casado, Anuska Llano, et al.. (2012). Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller. PLoS ONE. 7(2). e31928–e31928. 20 indexed citations
9.
Ballana, Ester, Jordi Senserrich, Eduardo Pauls, et al.. (2010). ZNRD1 (Zinc Ribbon Domain–Containing 1) Is a Host Cellular Factor That Influences HIV‐1 Replication and Disease Progression. Clinical Infectious Diseases. 50(7). 1022–1032. 41 indexed citations
10.
Casado, Concha, María Pernas, Virginia Martin, et al.. (2007). Coinfection and Superinfection in Patients with Long‐Term, Nonprogressive HIV‐1 Disease. The Journal of Infectious Diseases. 196(6). 895–899. 34 indexed citations
11.
Pruvost, Alain, Eugènia Negredo, Henri Bénech, et al.. (2005). Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 49(5). 1907–1914. 90 indexed citations
12.
García‐Reyero, Natàlia, Eulàlia Grau, Montserrat Castillo, et al.. (2001). MONITORING OF ENDOCRINE DISRUPTORS IN SURFACE WATERS BY THE YEAST RECOMBINANT ASSAY. Environmental Toxicology and Chemistry. 20(6). 1152–1152. 11 indexed citations
13.
Grau, Eulàlia, et al.. (1986). Coincident Multiple Myeloma and Non-Hodgkin’s Lymphoma with 2 Serum Monoclonal Immunoglobulins. Acta Haematologica. 75(3). 183–185. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026